(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) are a response to EGFR-tyrosine kinase inhibitor. However, a lack of sufficient tumor tissue has been a limitation for determining EGFR mutation status in clinical practice. The objective of this study was to pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jian, Xiao, Nan J., Chen, Min, Zhou, Wen L., Zhang, Yao W., Wang, Shuang, Dai, Yong M., Li, Lu, Zhang, Yue, Li, Qin Y., Li, Xiang Z., Yang, Mi, Wu, Hu B., Chen, Long H., Liu, Lai Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265876/
https://www.ncbi.nlm.nih.gov/pubmed/27472739
http://dx.doi.org/10.1097/MD.0000000000004421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265876/
https://www.ncbi.nlm.nih.gov/pubmed/27472739
http://dx.doi.org/10.1097/MD.0000000000004421

Ejemplares similares